Central Admixture Pharmacy Services, Inc.

Central Admixture Pharmacy Services, Inc., doing business as Caps, manufactures and delivers compounded sterile pharmaceutical preparations — total parenteral nutrition solutions, intravenous admixtures, lipid emulsions, and cardioplegia orders — to federal healthcare agencies as a large-business prime contractor on full-and-open federal contracts with no set-aside posture. The Irvine, California-based for-profit pharmaceutical compounding organization operates as both a 503A traditional pharmacy and 503B outsourcing facility and has held over 50 prime federal contracts since 2019, generating combined potential value of $81.9 million across 756 awards.

Caps competes exclusively as a prime contractor (100% of awards) across a portfolio concentrated in Drugs and Biologicals (541 awards) and Medical and Surgical Instruments, Equipment, and Supplies (112 awards) under NAICS 325412 (Pharmaceutical Preparation Manufacturing). Representative named work includes a $826,242 delivery order from Veterans Integrated Service Network 10 for patient-specific TPN, lipid emulsions, and cardioplegia to the LTC Charles S. Kettles VA Medical Center (awarded January 2026, completion January 2027); a $6 million single-award indefinite-delivery contract from the NIH Clinical Center for 503A and 503B compounding services (awarded April 2024, performance through September 2025, two $750,000 delivery orders issued); a $4 million single-award IDIQ from VA VISN 22 for compounded sterile TPN supplies (awarded September 2024, completion September 2026, eight delivery orders ranging from $54,633 to $217,130); and a $966,766 single-award indefinite-delivery contract from the Defense Health Agency for sterile admixture pharmacy services (awarded May 2022, completion September 2026, five delivery orders issued).

Customer concentration skews heavily to defense and veteran healthcare. The top five funding agencies by combined potential value — the Defense Health Agency ($17.6 million across 26 awards), the NIH Clinical Center ($15.7 million across 18 awards), the Department of the Navy Bureau of Medicine and Surgery ($11.4 million across 33 awards), VA VISN 10 ($8.7 million across 32 awards), and VA VISN 8 ($7.2 million across 44 awards) — account for approximately 74 percent of combined potential value. By award count, VA VISN 8 leads with 44 awards, followed by the Navy (33 awards), VA VISN 10 (32 awards), and VA VISN 2 (27 awards); these four customers represent 21 percent of all awards. Caps serves 18 distinct federal agencies across the VA, Defense Health Agency, NIH, Indian Health Service, Department of the Army Medical Command, and Department of the Navy.

Caps holds seven named single-award indefinite-delivery contracts: the $6 million NIH Clinical Center 503A/503B contract; the $4 million VA VISN 22 TPN supplies contract; the $966,766 Defense Health Agency sterile admixture contract (completion September 2026); a $826,242 VA VISN 10 patient-specific TPN contract (completion January 2030); a $444,584 VA VISN 10 pharmacy compounding services contract (completion September 2029); a $382,476 VA VISN 15 TPN compounding contract (completion August 2027); and a $280,664 VA VISN 23 pharmacy services contract (completion September 2023). Task orders under these vehicles range from $29,467 to $750,000; the highest-volume vehicle is VA VISN 22 with eight delivery orders totaling at least $1.1 million as of September 2026.

Activity has remained roughly flat over the past five years — 19 awards in 2022, declining to 10 in 2023, rebounding to 19 in 2024, and tapering to 12 in 2025 and 4 through May 2026 — with 10 awards (combined potential value $2.3 million) reaching ultimate completion within the next twenty-four months and therefore exposed to recompete. Obligated dollars total $25.9 million (32 percent of combined potential value), indicating that most awards remain unutilized or partially executed. The vendor maintains no subcontract footprint and does not appear in any named parent vehicle as a consortium member or sub contractor.